Alimera Sciences

Alimera Sciences Inc.
Nasdaq: ALIM (2010-24)
Industry
Founded2003 (2003)
Defunct2024 (2024)
FateAcquired by
  • ANI Pharmaceuticals, Inc
HeadquartersAlpharetta, Georgia, US
Key people
Rick Eiswirth, (president and CEO)
ProductsPharmaceuticals
Revenue $54.1 Million(2019)

Alimera Sciences, Inc. was a biopharmaceutical sales company based in Alpharetta, Georgia that specialized in the commercialization and sales of prescription ophthalmic pharmaceuticals. The company's main selling focus was on diseases affecting the back of the eye, or retina.

In September, 2024, ANI Pharmaceuticals, Inc. announced that it had completed its purchase of the company.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.